Silver Book Fact

Decrease in AFib hospitalization rates

The use of practice guidelines in atrial fibrillation patients saw a decrease in rate of hospitalization from 74%to 38%.

Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al. Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs. Am J Cardiol. 2003; 92(6): 677-81. http://www.ajconline.org/article/S0002-9149(03)00821-X/abstract

Reference

Title
Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs
Publication
Am J Cardiol
Publication Date
2003
Authors
Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al
Volume & Issue
Volume 92, Issue 6
Pages
677-81
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • Cost-savings associated with optimal anticoagulation in AFib patients
    If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct…  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.